Other languages Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Delayed NSE India S.E. Other stock markets 09:16:12 14/05/2024 am IST			5-day change	1st Jan Change
300.7 ^INR	+2.04%		-5.89%	-27.46%

19/03	Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	MT
08/03	Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs	19/03
Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products	08/03
Venus Remedies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Venus Remedies Gets Ukraine Marketing Approval for Chemotherapy Drug, Antibiotics	13/02
Indian Equities Clock Sharp Losses on Wednesday Due to Widespread Selling	20/12
Indian Equities Score Another Record Highs on Tuesday, Lifted by Ruling Party's State Polls Win	05/12
Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and Philippines	01/12
Venus Remedies' Consolidated Profit Jumps in Fiscal Q2	27/11
Venus Remedies Limited Receives Marketing Approval from the Philippines for Six Key Chemotherapy Drugs	16/23/16
Venus Remedies Limited Expands Global Reach with the Launch of Elores in Ecuador	12/23/12
Venus Remedies Limited Extends Its Oncology Portfolio in South Eastern Europe with Serbian Marketing Approval for Gemcitabine and Docetaxel	20/23/20
Venus Remedies Launches its R&D Drug Elores, in the $1.4 Billion Pharmaceutical Market in Oman	17/23/17
Venus Remedies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/23/14
Indian Equities Close Higher as US, Eurozone Inflation Cools	31/23/31
Venus Remedies Limited Extends Its Reach in the Association of Southeast Asian Nations Region, South America and Eastern Europe with Marketing Authorization for Key Cancer Drugs from Philippines, Paraguay, Georgia and Moldova	31/23/31
Venus Remedies Limited Consolidates its Position in the Guff Cooperation Council, Association of South East Asian Nations	05/23/05
Venus Remedies Limited Receives Ukrainian GMP Approval for Its Carbapenem, Oncology Parenteral Facilities	07/23/07
Venus Remedies Limited Reports Earnings Results for the Full Year Ended March 31, 2023	29/23/29
Venus Remedies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	29/23/29
Venus Remedies Limited Announces Resignation of Pravindra Singh Chauhan as Independent Director	04/23/04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Other languages

Filters